245 related articles for article (PubMed ID: 2862823)
1. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
Rousseau MF; Cheron P; Nannan M; Vincent MF; Lavenne F; Pouleur H
Ann Med Interne (Paris); 1985; 136(3):247-50. PubMed ID: 2862823
[TBL] [Abstract][Full Text] [Related]
2. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
3. Effects of the beta 1-adrenergic receptor partial agonist xamoterol on left ventricular diastolic function. An evaluation after 1-6 years of oral therapy.
Pouleur H; Etienne J; Van Mechelen H; Gurné O; Rousseau MF
Circulation; 1990 Feb; 81(2 Suppl):III87-92. PubMed ID: 1967560
[TBL] [Abstract][Full Text] [Related]
4. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
Amende I; Simon R; Hood WP; Lichtlen PR
Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
[TBL] [Abstract][Full Text] [Related]
5. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
6. Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.
Pouleur H; Hanet C; Rousseau MF; van Eyll C
Circulation; 1990 Aug; 82(2 Suppl):I89-96. PubMed ID: 1973644
[TBL] [Abstract][Full Text] [Related]
7. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
de Feyter PJ; Serruys PW; Suryapranata H
Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic and humoral changes following intravenous administration of xamoterol in patients with heart failure and coronary heart disease].
Erlemeier HH; Kupper W; Bleifeld W
Z Kardiol; 1990 Feb; 79(2):126-33. PubMed ID: 1969685
[TBL] [Abstract][Full Text] [Related]
9. [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease].
Rousseau MF; Pouleur H; Etienne J; Mengeot P; Cheron P
Arch Mal Coeur Vaiss; 1984 Jan; 77(1):76-84. PubMed ID: 6142702
[TBL] [Abstract][Full Text] [Related]
10. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Marlow HF
Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
[TBL] [Abstract][Full Text] [Related]
11. Xamoterol in patients with dilated cardiomyopathy: an increase in beta-receptors in lymphocytes.
Watanabe K; Hirokawa Y; Shibata A
J Cardiol; 1988 Dec; 18(4):1015-25. PubMed ID: 2908309
[TBL] [Abstract][Full Text] [Related]
12. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
13. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
[TBL] [Abstract][Full Text] [Related]
14. Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.
Rousseau MF; Pouleur H; Vincent MF
Am J Cardiol; 1983 May; 51(8):1267-74. PubMed ID: 6133444
[TBL] [Abstract][Full Text] [Related]
15. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
Holubarsch C; Hasenfuss G; Thierfelder L; Just H
Basic Res Cardiol; 1991; 86 Suppl 1():107-12. PubMed ID: 1827977
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction.
Pouleur H; Rousseau MF; Hanet C; Marlow HF; Charlier AA
Circ Res; 1987 Oct; 61(4 Pt 2):I91-5. PubMed ID: 2820612
[TBL] [Abstract][Full Text] [Related]
17. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
Pouleur H; van Eyll C; Hanet C; Cheron P; Charlier AA; Rousseau MF
Circulation; 1988 May; 77(5):1081-9. PubMed ID: 2896076
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
Vik-Mo H; Yasay G; Maroko PR; Ribeiro LG
J Cardiovasc Pharmacol; 1985; 7(4):784-90. PubMed ID: 2410722
[TBL] [Abstract][Full Text] [Related]
20. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
